Literature DB >> 11884275

Leukocyte recruitment into developing atherosclerotic lesions: the complex interaction between multiple molecules keeps getting more complex.

Michael E Rosenfeld.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884275     DOI: 10.1161/hq0302.104847

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  6 in total

1.  Monocyte recruitment to endothelial cells in response to oscillatory shear stress.

Authors:  Tzung K Hsiai; Sung K Cho; Pak K Wong; Mike Ing; Adler Salazar; Alex Sevanian; Mohamad Navab; Linda L Demer; Chih-Ming Ho
Journal:  FASEB J       Date:  2003-09       Impact factor: 5.191

Review 2.  Targeting the vulnerable plaque: the evolving role of nuclear imaging.

Authors:  John R Davies; James F Rudd; Tim D Fryer; Peter L Weissberg
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

Review 3.  Carotenoids and cardiovascular disease.

Authors:  Graziano Riccioni
Journal:  Curr Atheroscler Rep       Date:  2009-11       Impact factor: 5.113

4.  BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice.

Authors:  Tin Kyaw; Peng Cui; Christopher Tay; Peter Kanellakis; Hamid Hosseini; Edgar Liu; Antonius G Rolink; Peter Tipping; Alex Bobik; Ban-Hock Toh
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

5.  Signal regulatory protein alpha negatively regulates beta2 integrin-mediated monocyte adhesion, transendothelial migration and phagocytosis.

Authors:  Dan-Qing Liu; Li-Min Li; Ya-Lan Guo; Rui Bai; Chen Wang; Zhen Bian; Chen-Yu Zhang; Ke Zen
Journal:  PLoS One       Date:  2008-09-29       Impact factor: 3.240

6.  Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects.

Authors:  Meei-Maan Wu; Hung-Yi Chiou; I-Ching Ho; Chien-Jen Chen; Te-Chang Lee
Journal:  Environ Health Perspect       Date:  2003-08       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.